Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107657

Effects of Intraduodenal Administration of HCl and Glucose on Circulating Immunoreactive Secretin and Insulin Concentrations

Guenther Boden, Noorjehan Essa, Oliver E. Owen, Frederick A. Reichle, and Walter Saraga

Department of Medicine and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Department of Surgery and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Find articles by Boden, G. in: PubMed | Google Scholar

Department of Medicine and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Department of Surgery and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Find articles by Essa, N. in: PubMed | Google Scholar

Department of Medicine and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Department of Surgery and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Find articles by Owen, O. in: PubMed | Google Scholar

Department of Medicine and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Department of Surgery and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Find articles by Reichle, F. in: PubMed | Google Scholar

Department of Medicine and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Department of Surgery and the General Clinical Research Center, Temple University Health Sciences Center, Philadelphia, Pennsylvania 19140

Find articles by Saraga, W. in: PubMed | Google Scholar

Published April 1, 1974 - More info

Published in Volume 53, Issue 4 on April 1, 1974
J Clin Invest. 1974;53(4):1185–1193. https://doi.org/10.1172/JCI107657.
© 1974 The American Society for Clinical Investigation
Published April 1, 1974 - Version history
View PDF
Abstract

A new radioimmunoassay for secretin was used to investigate (a) serum secretin responses to intraduodenally infused HCl and glucose, (b) the metabolic half-life and the volume of distribution of exogenous secretin and (c) the effect of endogenously released secretin on insulin secretion in 25 anesthetized dogs. Portal and femoral venous blood samples were taken simultaneously before, during, and after intraduodenal infusion of HCl (21 meq/30 min) and glucose (131 ml/30 min). Control experiments were performed with intraduodenal infusion of saline.

Mean portal venous immunoreactive secretin concentration of six dogs rose from 313 μU/ml before to 1,060 μU/ml 10 min after initiation of the intestinal acidification (P < 0.005). Femoral venous immunoreactive secretin concentration rose from 220 μU/ml before to 567 μU/ml 15 min after intestinal acidification (P < 0.01). Secretin concentrations remained elevated during the remainder of the infusion.

In the same six dogs mean portal venous immunoreactive insulin concentration rose from 38 μU/ml before to 62 μU/ml at the end of the infusion (P < 0.05). Peripheral immunoreactive insulin, glucose, and free fatty acid concentrations, however, did not change significantly.

Pancreatic exocrine function was studied in four dogs. The rise in secretin concentration was followed promptly by a highly significant increase in exocrine pancreatic flow rate and bicarbonate secretion, indicating biological activity of the circulating immunoreactive secretin.

The effect of intraduodenal infusion of glucose on immunoreactive secretin concentration was studied in 12 dogs. Glucose in concentrations ranging from 2.5% to 10% had no detectable influence on portal or peripheral secretin concentration. Infusion of 50% glucose caused a slight decline in secretin concentration.

The metabolic clearance rate, half-life of disappearance, and volume of distribution of exogenous secretin was studied in three dogs by the constant infusion technic. The metabolic clearance rate was 730±34 ml/min, volume of distribution was 17.4±0.8% of body weight, and the half-life of disappearance was 2.8±0.1 min. It could be calculated that 1.38 U/kg-h-1 of endogenous secretin was released into the peripheral circulation during the steady state period of the HCl infusion experiments.

The data indicated that immunoreactive secretin was released rapidly after intestinal acidification, continued to be secreted throughout the duration of HCl infusion, and was promptly distributed in the extracellular compartment. Furthermore, they suggested that endogenously released secretin could stimulate insulin secretion. The HCl-mediated insulinogenic effect of immunoreactive secretin, however, was too weak to influence peripheral immunoreactive insulin, glucose, and free fatty acid concentrations.

The failure of intraduodenal glucose to stimulate secretin release suggests that secretin is not the insulin-stimulatory factor released from the gastrointestinal tract in response to glucose.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1185
page 1185
icon of scanned page 1186
page 1186
icon of scanned page 1187
page 1187
icon of scanned page 1188
page 1188
icon of scanned page 1189
page 1189
icon of scanned page 1190
page 1190
icon of scanned page 1191
page 1191
icon of scanned page 1192
page 1192
icon of scanned page 1193
page 1193
Version history
  • Version 1 (April 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts